4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
X4 Pharmaceuticals, Inc. (XFOR) operates in the Biotechnology industry and is headquartered in Boston, United States with about 45 employees. Its market capitalization is roughly $374 million. In the fiscal year ended 2025-12-31, XFOR reported $35M in revenue and ($79M) in net income.
X4 Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases of the immune system.
Interactive charts & full statements → Open the XFOR valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $35M | $3M | $0M | $0M | — |
| Gross Profit | $29M | $2M | $0M | $0M | — |
| Operating Income (EBIT) | ($87M) | ($141M) | ($108M) | ($88M) | — |
| Net Income | ($79M) | ($38M) | ($101M) | ($94M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $3M | $3M | $2M | $2M | $29M | — |
| Gross Profit | $2M | $2M | $1M | $2M | $24M | — |
| Operating Income (EBIT) | ($20M) | ($24M) | ($28M) | ($26M) | ($9M) | — |
| Net Income | ($20M) | ($24M) | ($30M) | ($26M) | $0M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $290M | $146M | $147M | $156M | — |
| Total Liabilities | $104M | $124M | $96M | $82M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive XFOR viewer.
About TickerBase · Data methodology & sources